Benzinga | Nov 10, 2021 06:47AM EST

HC Wainwright & Co. Maintains Buy on Kronos Bio, Raises Price Target to $36

HC Wainwright & Co. analyst Robert Burns maintains Kronos Bio (NASDAQ:KRON) with a Buy and raises the price target from $35 to $36.